Fundz

United States Pharmacopeia Appoints Amanda Cowley as Chief Growth Officer

PRIVATEMay 05, 2025

Position

Chief Science Officer

Company

U.S. Pharmacopeia

Fouad Atouf
fa@usp.org
RockvilleManufacturingHealth CarePharmaceutical

Description

USP has announced the appointment of Amanda Cowley as Chief Growth Officer, effective July 1, 2025, as part of several key leadership changes. Additionally, Fouad Atouf, PhD has been named Chief Science Officer and Ken Alexander, JD will take over from Amanda Cowley as General Counsel and will continue to serve as head of Global Legal.

Other recent leadership changes in Pharmaceutical and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at U.S. Pharmacopeia, and when

A new leader at U.S. Pharmacopeia brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day U.S. Pharmacopeia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at U.S. Pharmacopeia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at U.S. Pharmacopeia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

U.S. Pharmacopeia

Location

Rockville, Maryland, United States

About

USP is an independent scientific non-profit organization that collaborates with the world's top experts in health and science to develop quality resources and standards for medicines, dietary supplements and food ingredients. This includes actively collaborating with academic research centers, industry, and regulators to help with the adoption and implementation of advanced manufacturing technologies. Through our resources, standards, advocacy and education, USP helps increase the availability of quality medicines, supplements and foods for billions of people worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment U.S. Pharmacopeia changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Payal
Likely contact at this company
••••••••@••••••••

See Payal's verified email →

Paula
Likely contact at this company
••••••••@••••••••

See Paula's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for U.S. Pharmacopeia's next move

Learn about Strategic plan

U.S. Pharmacopeia changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.